You are here: Industry Insights > nasal spray

News List

Glenmark, Bausch Health partner to commercialise RYALTRIS nasal spray in Canada expresspharma
March 23, 2021
RYALTRIS is currently under review by Health Canada with a proposed indication for the treatment of seasonal allergic rhinitis in adults and children over 12 years of age.
Could a nasal spray prevent coronavirus transmission? worldpharmanews
February 22, 2021
A nasal antiviral created by researchers at Columbia University Vagelos College of Physicians and Surgeons blocked transmission of SARS-CoV-2 in ferrets, suggesting the nasal spray also may prevent infection in people exposed to the new coronavirus ...
Glenmark gets marketing approval for Ryaltris, single nasal spray in Russia expresspharma
February 22, 2021
Glenmark Pharmaceuticals announced that its Swiss subsidiary, Glenmark Specialty, received marketing approval from the Ministry of Health of the Russian Federation for its innovative Ryaltris Nasal Spray – a fixed-dose combination nasal spray.
New system could deliver schizophrenia medicine directly to brain europeanpharmaceuticalreview
January 20, 2021
A team has created a nasal spray as a drug delivery system to get schizophrenia medication directly to the brain.
Research on preventative nasal spray, which protects against COVID-19 and common cold, published in leading peer-reviewed academic journals prnasia
December 18, 2020
Research on a novel nasal spray therapy, INNA-051, which has been shown to reduce COVID-19 viral replication by up to 96 percent in a gold standard ferret study, has been published in two leading international peer-reviewed journals.
Eureka Therapeutics’ nasal spray protects against Covid-19 in studies pharmaceutical-technology
December 16, 2020
Eureka Therapeutics has announced that preclinical results of its InvisiMask Human Antibody Nasal Spray in mice showed it offers up to ten hours protection against SARS-CoV-2 S pseudotyped virus infection.
Potential anti-COVID-19 nasal spray developed by researchers europeanpharmaceuticalreview
November 23, 2020
A new nasal spray with ingredients already approved for use in humans could be used to protect people against COVID-19.
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study prnasia
September 28, 2020
A novel nasal treatment developed to boost the natural human immune system to fight common colds and flu, has proved remarkably successful in reducing COVID-19 viral replication test results, released today, reveal.
CEBINA Identifies Common Antihistamine Nasal Spray as a Potential Anti-COVID-19 Approach americanpharmaceuticalreview
July 20, 2020
CEBINA GmbH has announced positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays.
Patheon to Manufacture FDA-Approved Nasal Spray contractpharma
July 20, 2020
Evoke Pharma initiates commercial manufacturing of Gimoti with the CDMO.

Previous page 1 2 3 4 Next page